Trilogy Capital’s Bunge Global BG Stock Holding History

Trilogy Capital’s Portfolio BG Stock Details BG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-403	Closed	-$28K	–	178
2018 Q3	$28K	Buy	+403	New	+$26.6K	﹤0.01%	245

Other funds holding BG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CGC

Continental Grain Company New York $366M AUM 0.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Trilogy Capital's BG Position: Q4 2018 in Review

Trilogy Capital sold out of Bunge Global (BG) in Q4 2018, closing a stake of 403 shares — an estimated $28K sold.

Trilogy Capital first reported a position in BG in Q3 2018 and held it in 1 quarter. The position peaked at $28K in Q3 2018. 386 funds tracked by Wall St. Rank hold BG as of Q4 2018.

Trilogy Capital reported no remaining Bunge Global position as of Q4 2018 after selling out during the quarter.
Trilogy Capital sold 403 Bunge Global shares in Q4 2018, an estimated $28K.
Trilogy Capital first reported a position in Bunge Global in Q3 2018 and held it in 1 quarter.
Trilogy Capital's Bunge Global position peaked at $28K in Q3 2018.
386 funds tracked by Wall St. Rank held Bunge Global as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.